Psoas abscess : A primer for the internistTAIWO, Babafemi.Southern medical journal (Birmingham). 2000, Vol 94, Num 1, pp 2-5, issn 0038-4348Article

Understanding transmitted HIV resistance through the experience in the USATAIWO, Babafemi.International journal of infectious diseases. 2009, Vol 13, Num 5, pp 552-559, issn 1201-9712, 8 p.Article

Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV Infection: Rationale and ResultsTAIWO, Babafemi; MURPHY, Robert L; KATLAMA, Christine et al.Drugs (Basel). 2010, Vol 70, Num 13, pp 1629-1642, issn 0012-6667, 14 p.Article

Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapyBHATIA, Ramona; RYSCAVAGE, Patrick; TAIWO, Babafemi et al.Journal of neurovirology. 2012, Vol 18, Num 4, pp 247-255, issn 1355-0284, 9 p.Article

Unmet therapeutic needs in the new era of combination antiretrovirat therapy for HIV-1TAIWO, Babafemi; HICKS, Charles; ERON, Joseph et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 6, pp 1100-1107, issn 0305-7453, 8 p.Article

Antiretroviral reduction: is it time to rethink the unthinkable?COLASANTI, Jonathan; MARCONI, Vincent C; TAIWO, Babafemi et al.AIDS (London). 2014, Vol 28, Num 7, pp 943-947, issn 0269-9370, 5 p.Article

Primary human immunodeficiency virusTAIWO, Babafemi O; HICKS, Charles B.Southern medical journal (Birmingham). 2002, Vol 95, Num 11, pp 1312-1317, issn 0038-4348, 6 p.Article

Man with a Right Thigh MassTAIWO, Babafemi O; GRANT, Thomas; WAYNE, Jefferey et al.Clinical infectious diseases. 2007, Vol 44, Num 3, issn 1058-4838, 417, 462-463 [3 p.]Article

Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected PatientsRYSCAVAGE, Patrick; KELLY, Sean; LI, Jonathan Z et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 3585-3598, issn 0066-4804, 14 p.Article

Clinical Outcomes of Adolescents and Young Adults in Adult HIV CareRYSCAVAGE, Patrick A; ANDERSON, Evan J; SUTTON, Sarah H et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 2, pp 193-197, issn 1525-4135, 5 p.Article

Can tumor necrosis factor α blockade predispose to severe babesiosis?TAIWO, Babafemi; LEE, Chin; VENKAT, Deepak et al.Arthritis care and research. 2007, Vol 57, Num 1, pp 179-181, issn 0893-7524, 3 p.Article

Shigella sonnei bacteremia : Two adult cases and review of the literatureHAWKINS, Claudia; TAIWO, Babafemi; BOLON, Maureen et al.Scandinavian journal of infectious diseases. 2007, Vol 39, Num 2, pp 170-173, issn 0036-5548, 4 p.Article

Antiretroviral Drug Resistance in HIV-1―Infected Patients Experiencing Persistent Low-Level Viremia During First-Line TherapyTAIWO, Babafemi; GALLIEN, Sebastien; AGA, Evgenia et al.The Journal of infectious diseases. 2011, Vol 204, Num 4, pp 515-520, issn 0022-1899, 6 p.Article

Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) studyWOHL, David A; ARNOCZY, Gretchen; BELINDA HA et al.Antiviral therapy (London). 2014, Vol 19, Num 2, pp 141-147, issn 1359-6535, 7 p.Article

Efficacy of a nucleoside-sparing regimen of darunavir/ ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)TAIWO, Babafemi; LU ZHENG; ERON, Joseph J et al.AIDS (London). 2011, Vol 25, Num 17, pp 2113-2122, issn 0269-9370, 10 p.Article

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trialPOLLARD, Richard B; ROCKSTROH, Jürgen K; ARASTEH, Keikawus et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 4, pp 291-300, issn 1473-3099, 10 p.Article

Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: Multicenter AIDS Cohort StudyHECHTER, Rulin C; BUDOFF, Matthew; DETELS, Roger et al.Atherosclerosis. 2012, Vol 223, Num 2, pp 433-436, issn 0021-9150, 4 p.Article

Factors associated with remaining on initial randomized efavirenz-containing regimensSMURZYNSKI, Marlene; KUNLING WU; SCHOUTEN, Jeffrey T et al.AIDS (London). 2013, Vol 27, Num 12, pp 1887-1897, issn 0269-9370, 11 p.Article

Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimenGERSCHENSON, Mariana; KIM, Courtney; BELSEY, Elizabeth et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 6, pp 1244-1250, issn 0305-7453, 7 p.Article

Connection Domain Mutations During Antiretroviral Treatment Failure in Mali: Frequencies and Impact on Reverse Transcriptase Inhibitor ActivityISSIAKA MAIGA, Almoustapha; PENUGONDA, Sudhir; CALVEZ, Vincent et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 3, pp 293-296, issn 1525-4135, 4 p.Article

Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapyTAIWO, Babafemi; YANIK, Elizabeth L; KAHN, James S et al.AIDS (London). 2013, Vol 27, Num 10, pp 1593-1602, issn 0269-9370, 10 p.Article

Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources settingISSIAKA MAIGA, Almoustapha; BOCAR FOFANA, Djeneba; MURPHY, Robert et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 12, pp 2943-2948, issn 0305-7453, 6 p.Article

Long-Term Serologic Responses to the Pneumocystis jirovecii Major Surface Glycoprotein in HIV-Positive Individuals With and Without P. jirovecii InfectionWALZER, Peter D; DJAWE, Kpandja; MORRIS, Alison et al.The Journal of infectious diseases. 2009, Vol 199, Num 9, pp 1335-1344, issn 0022-1899, 10 p.Article

Assessing the Viorologic and Adherence Benefits of Patient-Selected HIV Treatment Partners in a Resource-limited SettingTAIWO, Babafemi O; IDOKO, John A; WELTY, Leah J et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 1, pp 85-92, issn 1525-4135, 8 p.Article

Hematologic, Hepatic, Renal, and Lipid Laboratory Monitoring After Initiation of Combination Antiretroviral Therapy in the United States, 2000―2010YANIK, Elizabeth L; NAPRAVNIK, Sonia; KAHN, James et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 2, pp 216-220, issn 1525-4135, 5 p.Article